BioSpace News Archive

HanAll Biopharma Co., Ltd. (KRX: 009420.KS) and Daewoong Pharmaceutical Co., Ltd. (KRX: 069620.KS) announced that they have entered into a co-development agreement with NurrOn Pharmaceuticals Inc., a Boston-based preclinical-stage biopharma.

Medtronic plc announced financial results for its fourth quarter and fiscal year 2023, which ended April 28, 2023.

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF) is pleased to announce several recent initiatives aimed at best positioning the company for the expected FDA approval of MDMA-assisted therapy (“MDMA-AT”) in the United States in the first half of 2024.

VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces it has successfully raised an additional €30 million in a Series B2 financing round.

CHA Medical & Bio Group, a global leader in stem cell research based in South Korea, announced its plan to establish the CHA Power Aging Research Translational Institute in Los Angeles.

Covalon Technologies Ltd., an advanced medical technologies company, announced its second quarter fiscal 2023 results.

Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical stage gene editing company developing ARCUS®-based in vivo gene editing and ex vivo allogeneic CAR T therapies, today announced that the Company will share an update on its allogeneic CAR T programs during a company-hosted webcast and conference call on May 31, 2023 at 8:30 AM ET.

Promore Pharma All AGM related documents are now available on the Company’s website.

Agenus, an immuno-oncology company with an extensive pipeline of clinical and preclinical-stage cancer treatments, announced that Dr. Garo Armen, Chairman and CEO, will participate in a fireside chat and investor one-on-ones at the upcoming Jefferies Healthcare Conference on June 8th at the Marriot Marquis in New York.

Alpha Teknova, Inc. announced that the Company will present and host individual and small group meetings at the following upcoming investor conference: